Versant Capital Management’s Vor Biopharma VOR Stock Holding History

Versant Capital Management’s Portfolio VOR Stock Details VOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$13.9K	Buy	+728	New	+$15.5K	﹤0.01%	2137

Other funds holding VOR

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Versant Capital Management's VOR Position: Q3 2026 in Review

Versant Capital Management opened a new position in Vor Biopharma (VOR) in Q3 2026: 728 shares worth $13.9K. The stake represents ﹤0.01% of the portfolio and ranks #2137 among its holdings.

11 funds tracked by Wall St. Rank hold VOR as of Q3 2026.

Versant Capital Management held 728 shares of Vor Biopharma worth $13.9K as of Q3 2026.
Vor Biopharma was a new Versant Capital Management position in Q3 2026.
Vor Biopharma made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2137 holding.
11 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.